| Literature DB >> 33003996 |
Huiyun Song1,2,3, Wenmai Mao1,2,3, Zhihao Duan1,2,3, Qingmin Que1,2,3, Wei Zhou1,2,3, Xiaoyang Chen1,2,3, Pei Li4,5,6.
Abstract
BACKGROUND: Before studying gene expression of different organisms, it is important to determine the best reference gene. At present, the most accurate method of detecting gene expression is quantitative real-time PCR (RT-qPCR). With this method, reference genes that are stable in different biological systems and under different conditions can be obtained. Toona ciliata Roem (T. ciliata). is a valuable and fast-growing timber specie. In this study, 20 reference genes were identified using RT-qPCR, as a primary prerequisite for future gene expression analysis. Four different methods, geNorm, NormFinder, BestKeeper, and RankAggreg were used to evaluate the expression stability of the 20 candidate reference genes in various tissues under different conditions.Entities:
Keywords: Hypsipyla robusta; MeJA; RT-qPCR; Reference gene; TcMYB3; Toona ciliata
Year: 2020 PMID: 33003996 PMCID: PMC7528382 DOI: 10.1186/s12870-020-02670-3
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Candidate reference genes, primer sequences, and characteristics of PCR amplification in T. ciliata
| Gene symbol | Gene Name | Primer: Forward/reverse | Amplification product size (bp) | standard curve | En | R |
|---|---|---|---|---|---|---|
| Actin-7 | F: TGATTGGGATGGAAGCAGCA R: GAACATGGTTGAACCGCCAC | 122 | y = − 3.5133x + 29.711 | 0.9259 | 0.9931 | |
| Phosphoglycerate kinase | F: CCGCAAGCTTCTTTGCGATT R: GGCTTGGATATTGGACCCGA | 145 | y = − 3.2649x + 26.93 | 1.0244 | 0.9985 | |
| 60S ribosomal protein L18a-1 | F: GCCTGGATGCCTTGTATGTTG R: GGGAAAGCACCAAGCAGTTTC | 108 | y = −3.5672x + 27.862 | 0.9332 | 0.9993 | |
| 60S ribosomal protein L13–1 | F: CCAACATGGCACTCATTCGC R: TTCCCAAGATGTGCTCGCAA | 200 | y = −3.4076x + 29.173 | 0.9654 | 0.9929 | |
| Histone deacetylase 6 | F: ATTGTCCGGTGATAGGTTGGG R: GTCTCGTAGCACCAACAACG | 153 | y = −3.4932x + 29.484 | 0.9332 | 0.9965 | |
| Histone acetyltransferase MCC1 | F: CTGCACGAATTGTGCTGGTC R: ACTGCACGACATGTTGGGAT | 193 | y = −3.5229x + 30.411 | 0.9225 | 0.9959 | |
| Protein phosphatase 2C 57 | F: TGTTGCAGCTTTACAAGGCG R: TGAACAAATCACCGCCTCCA | 185 | y = −3.3057x + 32.193 | 1.0068 | 0.9949 | |
| Probable protein phosphatase 2C 59 | F: TAAGCGATCGCCAACAAGGA R: CACGAGCTGCTGAGTATGTGA | 194 | y = −3.3119x + 27.157 | 1.0042 | 0.9974 | |
| Ubiquitin-conjugating enzyme E2 5B | F: GGAGGACCCATGATTGTTGC R: TCGAAGCGGATCTTGAAGGAG | 116 | y = −3.3156x + 25.529 | 1.0026 | 0.9987 | |
| Ubiquitin-conjugating enzyme E2–17 kDa | F: GCGTCGAAACGCATCTTGAA R: GAAACACCCCTCCCGCATAA | 148 | y = −3.4489x + 26.966 | 0.9496 | 0.999 | |
| elongation factor 1-alpha-like | F: CCGACCTTCTTCAGGTAGGAA R: TCCAAGGATGGTCAGACTCG | 164 | y = −3.4295x + 23.45 | 0.9570 | 0.9915 | |
| elongation factor 1-alpha-like | F: CACCCTTGGTGTGAAGCAAA R: GGTTGGTGGACCTCTCAATCA | 200 | y = −3.4128x + 27.077 | 0.9561 | 0.9992 | |
| Peptidyl-prolyl cis-trans isomerase CYP26–2 | F: GAAGCTGAAGTTGGTTGCCC R: GACGACCAGGGCTGAAACAT | 147 | y = −3.4393x + 30.33 | 0.9532 | 0.9952 | |
| Peptidyl-prolyl cis-trans isomerase CYP95 | F: ACCCGGCCTCTTATCTATGC R: ACAAGCTCCCCGAATACCAC | 117 | y = −3.4295x + 23.45 | 0.9041 | 0.9915 | |
| S-adenosylmethionine decarboxylase proenzyme | F: AGCGATCTGCTATGACCCTG R: CCCGCAGAACCTGATTGGTC | 102 | y = −3.3179x + 29.683 | 1.0017 | 0.9994 | |
| 18S rRNA factor 2 | F: GCTGCTAAGAGAGAGCGGG R: GGGAGCTCAGAATGGGTTCG | 128 | y = −3.4317x + 30.095 | 0.9561 | 0.9987 | |
| Tubulin alpha-3 chain | F: TACAACAGTTGGCGGCTGAT R: TGTACCGCGGAGATGTTGTT | 137 | y = −3.3568x + 29.206 | 0.9857 | 0.9998 | |
| Tubulin beta-5 chain | F: ACACACGCTGGACTTGACAT R: TCGCTACCTAACTGCTTCGG | 139 | y = −3.3349x + 32.62 | 0.9946 | 0.9996 | |
| Membrane-anchored ubiquitin-fold protein 1 | F: GCATTCTTGCTCAATGGCCT R: GGTTGTAACTCCACCAGGGA | 152 | y = −3.3956x + 28.572 | 0.9701 | 0.9984 | |
| TIP41-like protein | F: TGGTTGGAAGCAGGAAGGTT R: TTCACTTCCGCAGTATGGTG | 133 | y = −3.3332x + 31.127 | 0.9953 | 0.9992 | |
| Transcription factor MYB3 | F: CGCACCCATAACAACTCCCA R: TCTTTCACTTACTCCCTCTTCAGC | 178 | y = −3.4246x + 32.543 | 0.9589 | 0.9968 |
Fig. 1Distribution of threshold cycle (CT) values for 20 candidate reference genes across all samples. The middle line within each box represents the 50th percentile. The lower boundary and upper boundary of each box represent the 25th and 75th percentile respectively
Fig. 2Average expression stability values (M) for 20 candidate reference genes calculated by geNorm
Fig. 3Pairwise variations (V) for the 20 candidate reference genes calculated by geNorm to determine the optimal number of reference genes for accurate normalization. The threshold used was 0.15
Fig. 4Expression stability of the 20 candidate reference genes as calculated by NormFinder
Stability of expression of the 20 candidate reference genes, as calculated by BestKeeper
| Ranking | Different tissues | 4 °C treatment | MeJA treatment | PEG6000 treatment | All samples | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| gene | CV ± SD | gene | CV ± SD | gene | CV ± SD | gene | CV ± SD | gene | CV ± SD | gene | CV ± SD | gene | CV ± SD | gene | CV ± SD | |
| 1 | 1.16 ± 0.23 | 1.40 ± 0.31 | 1.73 ± 0.34 | 5.41 ± 1.38 | 0.73 ± 0.16 | 0.67 ± 0.14 | 3.89 ± 0.87 | 3.95 ± 0.87 | ||||||||
| 2 | 1.62 ± 0.36 | 1.70 ± 0.33 | 2.12 ± 0.47 | 5.48 ± 1.16 | 0.83 ± 0.18 | 0.83 ± 0.14 | 4.48 ± 1.02 | 4.16 ± 0.96 | ||||||||
| 3 | 2.05 ± 0.48 | 1.84 ± 0.44 | 2.54 ± 0.56 | 6.24 ± 1.36 | 0.90 ± 0.21 | 0.85 ± 0.19 | 5.10 ± 1.24 | 4.58 ± 1.02 | ||||||||
| 4 | 2.06 ± 0.37 | 1.87 ± 0.41 | 2.69 ± 0.62 | 6.42 ± 1.34 | 1.13 ± 0.21 | 0.87 ± 0.20 | 5.18 ± 1.18 | 4.90 ± 0.99 | ||||||||
| 5 | 2.31 ± 0.45 | 2.05 ± 0.40 | 3.09 ± 0.70 | 6.57 ± 1.34 | 1.19 ± 0.24 | 0.88 ± 0.20 | 5.26 ± 1.42 | 5.13 ± 1.02 | ||||||||
| 6 | 2.84 ± 0.63 | 2.25 ± 0.44 | 3.09 ± 0.54 | 7.32 ± 1.30 | 1.32 ± 0.27 | 0.89 ± 0.20 | 5.32 ± 1.36 | 5.14 ± 1.09 | ||||||||
| 7 | 2.95 ± 0.65 | 2.26 ± 0.50 | 3.17 ± 0.74 | 7.47 ± 1.48 | 1.51 ± 0.33 | 0.97 ± 0.19 | 5.43 ± 1.17 | 5.28 ± 1.17 | ||||||||
| 8 | 3.06 ± 0.71 | 2.46 ± 0.52 | 3.31 ± 0.66 | 7.54 ± 1.77 | 1.58 ± 0.34 | 0.97 ± 0.21 | 5.63 ± 1.32 | 5.33 ± 1.15 | ||||||||
| 9 | 3.12 ± 0.65 | 2.75 ± 0.64 | 3.42 ± 0.72 | 1.65 ± 0.35 | 1.34 ± 0.28 | 5.76 ± 1.24 | 5.36 ± 0.97 | |||||||||
| 10 | 3.17 ± 0.68 | 2.81 ± 0.48 | 3.66 ± 0.74 | 7.75 ± 1.66 | 1.67 ± 0.43 | 1.49 ± 0.34 | 6.07 ± 1.44 | 5.37 ± 1.14 | ||||||||
| 11 | 3.46 ± 0.78 | 2.87 ± 0.65 | 3.85 ± 0.84 | 7.95 ± 1.59 | 1.92 ± 0.44 | 1.57 ± 0.34 | 6.34 ± 1.43 | 5.48 ± 1.11 | ||||||||
| 12 | 3.61 ± 0.84 | 3.05 ± 0.62 | 3.96 ± 0.80 | 8.07 ± 1.68 | 2.09 ± 0.47 | 1.64 ± 0.32 | 6.37 ± 1.27 | 5.56 ± 1.19 | ||||||||
| 13 | 4.16 ± 0.86 | 3.36 ± 0.70 | 3.98 ± 0.93 | 8.08 ± 1.77 | 2.11 ± 0.47 | 1.68 ± 0.35 | 6.42 ± 1.43 | 5.86 ± 1.37 | ||||||||
| 14 | 4.35 ± 0.88 | 3.52 ± 0.65 | 4.34 ± 0.94 | 8.09 ± 1.70 | 2.21 ± 0.44 | 1.84 ± 0.38 | 6.61 ± 1.32 | 6.09 ± 1.47 | ||||||||
| 15 | 4.45 ± 0.97 | 3.99 ± 0.81 | 4.79 ± 1.00 | 8.83 ± 2.03 | 2.23 ± 0.41 | 1.93 ± 0.35 | 7.03 ± 1.55 | 6.61 ± 1.59 | ||||||||
| 16 | 4.75 ± 1.08 | 4.21 ± 0.69 | 5.07 ± 1.07 | 8.97 ± 1.81 | 2.31 ± 0.47 | 2.00 ± 0.40 | 7.04 ± 1.48 | 6.82 ± 1.38 | ||||||||
| 17 | 4.83 ± 0.97 | 4.48 ± 0.91 | 5.21 ± 0.87 | 9.33 ± 2.19 | 2.51 ± 0.48 | 2.00 ± 0.42 | 7.13 ± 1.62 | 7.61 ± 1.70 | ||||||||
| 18 | 4.84 ± 1.04 | 4.85 ± 1.04 | 5.38 ± 1.04 | 9.44 ± 1.57 | 2.52 ± 0.59 | 2.28 ± 0.49 | 7.51 ± 1.75 | 7.77 ± 1.66 | ||||||||
| 19 | 6.03 ± 1.04 | 5.49 ± 1.30 | 8.84 ± 1.94 | 12.30 ± 2.71 | 3.11 ± 0.71 | 3.27 ± 0.64 | 7.70 ± 1.97 | 8.11 ± 1.43 | ||||||||
| 20 | 8.36 ± 2.02 | 5.99 ± 1.67 | 10.94 ± 2.84 | 15.21 ± 3.73 | 4.58 ± 1.03 | 4.46 ± 1.04 | 10.75 ± 2.70 | 9.83 ± 2.37 | ||||||||
Stability of expression of the 20 candidate reference genes, as calculated by RankAggreg
| Ranking | Different tissues | 4 °C treatment | MeJA treatment | PEG6000 treatment | All samples | |||
|---|---|---|---|---|---|---|---|---|
| 1 | ||||||||
| 2 | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 6 | ||||||||
| 7 | ||||||||
| 8 | ||||||||
| 9 | ||||||||
| 10 | ||||||||
| 11 | ||||||||
| 12 | ||||||||
| 13 | ||||||||
| 14 | ||||||||
| 15 | ||||||||
| 16 | ||||||||
| 17 | ||||||||
| 18 | ||||||||
| 19 | ||||||||
| 20 |
Fig. 5Relative expression of TcMYB3 using the selected reference genes. The results were normalized using the selected stable reference genes (alone or in combination) and the unstable genes in sample sets across treatment with a H. robusta treatment in leaves, b H. robusta treatment in young stems, c different tissues, d 4 °C treatment, e MeJA treatment, f PEG6000 treatment. The bars indicate the standard error (±SE) evaluated from three biological replicates
Experimental details
| Experimental design | Tissue | Biological repetition | Sampling points | Number of samples |
|---|---|---|---|---|
| Different tissues | mature leaves, young leaves, flowers, shoots, young stems, roots | 3 | 1 | 18 |
| leaves, young stems | 3 | 6 | 36 | |
| 4 °C treatment | leaves | 3 | 5 | 15 |
| MeJA treatment | leaves | 3 | 5 | 15 |
| PEG6000 treatment | leaves | 3 | 5 | 15 |